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Bubble-lifetimea b s t r a c t
Phase-change nano-droplets (PCNDs) are sub-micron particles that are coated with phospholipid and
contain liquid-state perfluorocarbons such as perfluoropentane (boiling point = 29 C) and perfluorohex-
ane (boiling point = 57 C), which can vapourise upon application of ultrasound. The bubbles generated
by such reactions can serve as ultrasound contrast agents or HIFU sensitisers. However, the lifetime of
bubbles generated from PCNDs on ls-order is not well known. Knowledge of the condition of PCND-
derived bubbles on ls-order is essential for producing bubbles customised for specific purposes. In this
study, we use an optical measurement system to measure the vapourisation and stability of the bubbles
(bubble-lifetime) as well as the stability-controlling method of the nucleated bubbles on ls-order while
changing the internal composition of PCNDs and the ambient temperature. PCND-derived bubbles remain
in a bubble state when the boiling point of the internal composition is lower than the ambient temper-
ature, but lose their optical contrast after approximately 10 ls by re-condensation or dissolution when
the boiling point of the internal composition is higher than the ambient temperature. We reveal that
the superheating condition significantly affects the fate of vapourised PCNDs and that the bubble-
lifetime can be controlled by changing both the ambient temperature conditions and the internal com-
position of PCNDs.
 2016 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Medical applications of ultrasound started with imaging, and
the technology is still commonly used in clinical settings. Recently,
high-intensity focused ultrasound (HIFU) [1,2], which has thera-
peutic applications has been attracting considerable attention
because it can be conducted minimally invasively or non-
invasively.
However, problems exist for medical applications of ultrasound.
For example, detection of tumours is an extremely common prob-
lem in diagnostic ultrasound [3]; in conventional ultrasonic
images, it is difficult to identify boundaries between normal and
diseased tissues as there may be only a low contrast between
them. HIFU treatment also has the following drawbacks. First,
ultrasound is scattered and absorbed by fat, skin and other tissues
while propagating to a target region, which leads to energy defi-
ciency when treating the region. Second, to gain a high-intensityacoustic profile at the focus, unintended sites such as skin might
get burned because an approaching path overlaps at the skin in
each sonication. Therefore, HIFU is pulsed to avoid near-field heat-
ing and cooling time is set between subsequent exposures of HIFU
sequences [4]; this cooling time makes the treatment time signifi-
cantly longer.
Microbubbles have the potential to solve these issues. The
response of microbubbles to ultrasound is non-linear and that of
tissues to ultrasound is almost linear; thus, microbubbles can be
differentiated from the surrounding tissues, indicating their poten-
tial to be used as an ultrasound contrast agent [5]. In addition to
imaging purposes, microbubbles can act as a HIFU sensitiser. The
HIFU thermal coagulation effect can be accelerated by the presence
of microbubbles [6–9]. Several studies on phantom [10,11], ex vivo
[12] and in vivo [13,14] experiments have reported that there is
good correlation among the generation of acoustic cavitation, the
temperature-rise ratio and the peak temperature. These results
indicate that the presence of bubbles can improve the treatment
efficiency and reduce the treatment time under HIFU.
However, applications of microbubbles are limited because of
their size and fragility to ultrasound. They cannot permeate
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wall of cancerous tissue sites, which restricts their use only to
intravasculature. Intending to reach the extravascular tissue sites,
Kawabata et al. [15] proposed that nano-sized particles be used
for permeation and changed in size once they reach the extravas-
cular targeted tissue sites. Phase-change nano-droplets (PCNDs),
also known as acoustic nano-droplets, are sub-micron-sized parti-
cles, small enough to permeate through the vascular endothelial
cell gap junctions of cancerous tissue sites. PCNDs are coated with
phospholipid or encapsulated with protein or polymer and contain
liquid-state perfluorocarbons (PFCs) inside. Commonly used PCNDs
include perfluoropentane (PFP, boiling point = 29 C) and perfluo-
rohexane (PFH, boiling point = 57 C), and that Kawabata et al.
[15] showed that the boiling point can be modulated by mixing
of these specific PFCs. The major difference between these three
types of PCNDs is their boiling point. Application of ultrasound to
a PCND can vapourise the PFC inside a PCND and transform it into
a microbubbble. PCNDs are actively being researched as extravas-
cular ultrasound contrast agents [16–19], HIFU sensitisers [20–22]
and extravascular drug carriers [16,23,24], and vapourisation for
methods such as sonoporation [25,26] or the blood–brain opening
[27] are also being investigated.
While various studies have shown the potential for medical
applications of PCNDs, the underlying mechanism of the droplet
vapourisation process and the stability of the generated bubbles
are not well known. Resent research has advanced the knowledge
of the vapourisation mechanism. Shpak et al. [28] showed a super-
heated droplet vapourised by the focusing of a nonlinear wave
within the droplet. They have also shown detailed droplet vapouri-
sation dynamics in Ref. [29]. Reznik et al. [30] discussed the paths
that newly generated bubbles might take, and Sheeran et al. [31]
discussed several of the bubble phenomena that occur within an
ultrasound pulse. After exposure to vapourisation ultrasound
pulses, the behaviour of the vapourised PCND can be assumed to
fall into one of two groups; the short or the long-lifetime group.
Each group can be sub-classified into two cases: the recondensa-
tion and dissolution cases for the short-lifetime group, and the
remaining and coalescence cases for the long-lifetime group. Opti-
cal studies, especially those using high-speed imaging, are being
actively conducted to study the vapourisation processes and prop-
erties of the generated bubbles. However, ls-order optical obser-
vation of the vapourisation process has rarely been conducted,
and most previous studies have focused on the resulting bubbles
(time scale = ms to minute order). Several studies [29,32,33] have
taken ls or ns-order measurements of larger droplets (lm-size
droplets), which are thought to experience many of the same phe-
nomena as nm-size droplets. There might be differences in size
dynamics due to the effect of Laplace pressure, heat transfer and
rectified heat transfer [29]. Thus, the stability of bubbles generated
from PCNDs at ls-order is not well known. Besides the formation
of stable bubbles, as indicated in a previous vapourisation acoustic
measurement study [34], there is a significant possibility that the
bubbles re-condense into liquid droplets on ls order. Knowledge
of the conditions of PCND-derived bubbles on ls order is essential
for producing bubbles for specific purposes using PCNDs. Several
authors [30,31] have conducted high-speed optical imaging on
vapourisation of submicron-sized droplets. To the authors’ knowl-
edge, Reznik et al. [30] were the first authors that succeeded in ls-
order optical observation of the vapourisation processes of PFP
PCNDs (ranging from 100 nm to 1 lm in diameter with a mean
diameter of approximately 400 nm) at an ambient temperature
condition of 37 C. They imaged the initial vapourisation process
within 10 ls at 10 million frames per second (Mfps), and reported
that there were two states after the formation of the bubble; one
that remained as a stable bubble and one that disappeared within
approximately 10 ls. They focused on observation of individualand identical bubbles. Moreover, they used only one type of PCND.
It is important to conduct research on the vapourisation behaviour
as an entity and for different types of PCNDs.
Moreover, there is a significant demand for the stability-control
of PCND-derived bubbles. For application as an ultrasound contrast
agent or for sonoporation, the recondensation case is most desir-
able because vapourisation is thought to be repeated and reiter-
ated injections of PCNDs can be avoided. In contrast, the long-
lifetime group also can be used as ultrasound contrast agent with
using conventional ultrasound-imaging techniques such as the
pulse-inversion method. For application as a HIFU sensitiser, the
remaining and coalescence cases are desirable because one wants
to maintain the HIFU-sensitising effect for a long period of time
during HIFU-ablation therapy. We assumed that the boiling point
of the internal composition (PFC) of the PCND would be correlated
with the stability of the PCND-derived bubble; the PCND-derived
bubble is in a stable state when the boiling point is lower than
the ambient temperature, whereas it is in a meta-stable state when
the boiling point is higher than the ambient temperature.
In this study, we used an optical measurement system to mea-
sure the vapourisation and the stability (bubble-lifetime) and to
investigate the stability-controlling method of nucleated bubbles
at microsecond order while changing the internal composition of
the PCNDs and the ambient temperature.2. Materials and methods
2.1. Experimental set-up
The experimental set-up consisting of the optical system, the
ultrasound system, and the target gel phantom with PCNDs was
developed as illustrated in Fig. 1(A) to observe the vapourisation
of PCNDs and measure the bubble-lifetime.
2.2. PCNDs and gel phantoms
Three different types of PCNDs, whose internal compositions
were PFP, PFH and a mixture of the two (PFP:PFH = 1:1), were pro-
vided by Central Research Laboratory Hitachi (Tokyo, JAPAN). The
method of preparation of PCNDs can be found in Ref. [15,35]. A
laser-diffraction particle-size analyser (Beckman-Coulter
LS13320) was used to measure the particle-size distribution of
the PCND suspensions. The mean diameter of each type of PCND
was 380 ± 70, 370 ± 70 and 290 ± 130 nm, respectively. The droplet
concentrations were estimated using the total volume of PFC used
for PCNDs and the size distribution of each droplet [30]. As a result,
PFP, PFH and PFH–PFP mixture droplet concentrations were
4 1014, 4 1014, and 7 1014 droplets/ml, respectively. The main
known difference between the three types of PCNDs is the boiling
points of their internal compositions; the boiling point of PFP is
29 C, that of PFH is 57 C, and that of the mixture is 40 C (calcu-
lated from Raoult’s law and Clausius–Clapeyron Equation). The
three different types of PCNDs were embedded into the polyacry-
lamide gel separately to simulate PCND accumulation in a tumour.
PCNDs are expected to flow inside blood vessels or accumulate at
the extravascular tumour tissue sites [19,36] by the enhanced per-
meability and retention effect [37]. We intended to simulate those
accumulated at tumour tissues by incorporating PCNDs inside the
polyacrylamide gel, as did Kawabata et al. [34].
The method for preparation of the polyacrylamide gel solution
can be found in the literature [38,39]. PCNDs were embedded just
before the fixation by ammonium peroxodisulfate solution. The
final relative concentration of PCNDs to gel solution was set at
0.2% (v/v). Two types of gel solution (with and without PCNDs)
were prepared. First, the gel solution without PCNDs was poured
Fig. 1. (A) Schematic diagram of optically and acoustically simultaneous measurement experimental set-up. (B) Ultrasound transmission/reception sequence for the four-
shot-ultrasound vapourisation pulse. Four subsequent vapourisation pulses were transmitted at a repetition frequency of 17 kHz. The transmitted vapourisation-pulsed
ultrasound consisted of five cycles at 5 MHz with a peak negative pressure of 7.3 MPa and a peak positive pressure of 10.3 MPa. (C) The acoustic profile of the irradiated
ultrasound.
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ond, after the first gel solution had fixed, the gel solution with
PCNDs was poured on top of the first to make a two-layered PCND
gel phantom with a 5-mm-thick gel.
The temperatures inside the polyacrylamide gels were mea-
sured using a thermometer (Quick Check, SN-820, Netsuken,
JAPAN) during the polymerization in order to investigate the
exothermal effect of the polymerization.
Those gel phantoms were placed on the inverted microscope in
contact with the ultrasound diagnostic probe using a custom-made
jig. Ultrasonic gels were pasted between the gel phantom and the
ultrasound diagnostic probe to avoid the formation of an air gap
between two. The temperatures of the gel phantoms were set to
26 ± 1, 37 ± 1, or 48 ± 1 C by placing them inside thermostatic
baths (TB-1N, AS ONE, JAPAN) for more than 30 min until
just before the measurement of vapourisation. Differences
between ambient temperature and boiling point are summarized
in Table 1.
2.3. Ultrasound irradiation
A programmable ultrasound beam-former V1 (Verasonics, WA,
USA) driving a linear array-transducer ultrasound diagnostic probeTable 1
Difference between ambient temperature and boiling points of PCNDs’ internal
compositions.
Ambient temperature (C) Internal composition (B. P.)
PFP (29 C) PFP + PFH (40 C) PFH (57 C)
48 19 8 9
37 8 3 20
26 3 14 31(EUP-L73S, Hitachi Aloka Medical, JAPAN) was used to irradiate an
ultrasound vapourisation pulse. With this system, the vapourisa-
tion pulse could be irradiated within 128 channels of the probe.
Moreover, short-cycle pulsed ultrasound could be emitted to
vapourise PCNDs.
Two types of ultrasound transmission sequences were used for
this study; a single vapourisation pulse transmission and four sub-
sequent vapourisation pulse transmissions (with a pulse repetition
frequency of 17 kHz). The ultrasound transmission sequence for
four-shot vapourisation pulsed ultrasound is illustrated in Fig. 1
(B) and was used at an ambient temperature condition of 37 C.
The transmitted vapourisation pulsed ultrasounds were both 5
cycles at 5 MHz with a peak negative pressure of 7.3 MPa. The
acoustic profile is shown in Fig. 1(C). The focus of the transmitted
ultrasound was set at 30.1 mm from the transmission surface of
the ultrasound diagnostic probe. A multifunction generator
(WF1974, NF Corporation, JAPAN) was used to transmit a trigger
signal to activate an ultrasound transmission sequence and a
high-speed camera described in a later section.
2.4. Optical observation
For the optical system, PCND-derived bubbles and the transient
responses of PCNDs to ultrasound vapourisation pulses need to be
captured. The approximate amount of volume expansion that
might occur upon vapourisation of a PCND was 125 times, whereas
that of radial expansion was 5 times [40]. Thus, the approximate
mean diameter of PCND-derived bubbles was between 1 and
2 lm, which could be detected by an optical microscope. To
observe the transient responses of PCNDs to the exposed ultra-
sound vapourisation pulse, a ls-order high-speed imaging system
was necessary. Therefore, a high-speed camera (Hyper Vision HPV-
1, SHIMADZU, JAPAN) coupled with an inverted microscope
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objective lens (Plan Fluor 4/0.13 PhL DL, NIKON, JAPAN) was used
to observe the time-lapse behaviour of PCNDs’ vapourisation and
measure the bubble-lifetime.
Furthermore, the sizes of the bubbles during the vapourisation
were measured using a 40 magnification objective lens (Plan
Fluor 40/0.60 Ph2 ADL, NIKON, JAPAN) at 37 C. The maximum
frame rate of the high-speed camera was 1 Mfps, which enabled
ls-order observation of PCNDs vapourisation. The resolution of
the image was 312  260 pixels. 101 subsequent frames could be
recorded in total by the high-speed camera. A super high-
pressure mercury lamp (C-LHG1, NIKON, JAPAN) connected to an
appropriate power supply (C-SHG1, NIKON, JAPAN) was used for
the illumination light source. For the single vapourisation pulse
transmission ultrasound sequence, we set the frame rate of high-
speed camera to 1 Mfps (1 ls/frame) and exposure time to
0.5 ls. For the four-subsequent-vapourisation-pulse transmission
ultrasound sequence, we set the frame rate to 250 kfps (4 ls/
frame) and the exposure time to 0.5 ls.Fig. 2. Representative high-speed images of PCND vapourisation. Three different
types of PCNDs were used at an ambient temperature condition of 37 C; (left) PFH,
(centre) PFP–PFH mixture and (right) PFP. The high-speed camera was driven at
1 Mfps and images were taken at 1 ls intervals. Each image had its background
subtracted and inverted to emphasise generated bubbles. The scale bar represents2.5. Image processing
Each image frame was processed using Windows version
MATLAB (R2012b, MathWorks, MA, USA) to quantify the PCNDs’
vapourisation by calculating the vapourised area and intensity pro-
file of the video sequences.
The vapourisation of PCNDs led to the generation of microbub-
bles, which scattered the light and decreased the pixel intensity
values of the image at their positions. Background noise was
reduced by the subtraction approach. The image for subtraction,
which contains only background signals, was selected from the
video sequence prior to vapourisation. Afterwards, this background
image was subtracted from each frame. Pixel-intensity values of
the subtracted images were inverted and a threshold was set to
produce binary microbubble images. The threshold was chosen
using a single frame in the video sequence such that bubble cloud
is clearly discriminated from background signals. For one video
sequence, an arbitrary threshold was chosen and not changed for
each frame. However, threshold values were changed for other
video sequences because the luminous energy differed in each
video sequence. Pixels with a value of one (white areas) were
counted to estimate the cross-sectional area of the generated
microbubbles.
The sizes of the bubbles were measured throughout the image
sequences using the 40 magnification objective lens. The
elliptical ROIs were set by hand to the bubble contours and con-
verted to radius [41]. Noise in the images limited the measure-
ment of the bubble, such that the detection limit of the
diameter was approximately 1 lm in our optical experimental
setup. Moreover, bubbles that existed out of the focus of the
microscope such that the contours of the bubbles were blurred
were not included in the size measurements. Sizes were mea-
sured only for bubbles that remained in the focus of the
microscope.
For the four subsequent vapourisation-pulse transmission
ultrasound sequences, the intensity profiles of the video sequences
were calculated by generating subtracted images in the same man-
ner described above. Afterwards, a region of interest (ROI) of
28  260 pixels (0.58  5.40 mm) was set at the centre of the
vapourised area, and the summation was taken for the pixel values
in the lateral direction to obtain a 1  260 pixel intensity image.
Finally, the intensity was normalised by the maximum value of
the 1  260 pixel-intensity image. Normalisation was conducted
to average the results from several videos because the luminous
energy differed in each video sequence.3. Results
3.1. Optical measurements for the single-vapourisation-pulse
transmission ultrasound sequence
The recorded temperatures inside the polyacrylamide gels,
measured using a thermometer during the polymerization at
23.0 C (room temperature), exceeded 29.0 C for 160 s. The
observed peak temperature was 29.9 C. Therefore, the exothermal
effect of the polymerization might have affected the PFP droplet
stability.
Typical images for three different types of PCND taken at a
frame rate of 1 Mfps (at 1 ls intervals) by a high-speed camera,
(left) PFH, (centre) PFP–PFH mixture and (right) PFP, are shown
in Fig. 2. The scale bar represents 800 lm. Each image was sub-
tracted and inverted as described in the previous section.800 lm.
Fig. 4. The maximum vapourised areas for three different ambient temperatures
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shown in Fig. 3 for each type of PCND under different ambient tem-
perature conditions. The dashed line is the result for the ambient
temperature condition of 26 C, the solid line is the result for
37 C and the dotted line is the result for 48 C. Error bars were
added to every 5 ls data points. Peaks observed at 15, 27, 39 and
51 ls were due to the flickering. Hence, those were excluded.
The vapourised area could not be measured for PFP PCNDs at
48 C since the PFP droplets vapourised without exposing the
vapourisation pulse. From Fig. 3, PCND-derived bubbles disap-
peared in approximately 10 ls when the ambient temperature
was lower than the boiling point, while they remained in a bubble
state when the ambient temperature was higher than the boiling
point.
Fig. 4 illustrates the maximum vapourised areas for each ambi-
ent temperature of three different PCNDs. Error bars represent
double standard deviations. As shown in Fig. 4, ambient tempera-Fig. 3. Time-lapse change of mean vapourised area (N = 4) for each type of PCND;
(A) PFH, (B) PFP–PFH mixture and (C) PFP, at different ambient temperature
conditions. The dashed line is the result for the ambient temperature condition of
26 C, the solid line is the result for 37 C and the dotted line is the result for 48 C.
Error bars were added to every 5 ls data point.
and PCNDs. Error bars represents double standard deviations.ture conditions significantly affected the area of vapourisation, but
the difference between the ambient temperature and boiling point
did not.
Typical examples of a time series vapourisation process for sin-
gle PFH, PFP-PFP mixture and PFH droplets at 37 C are shown in
Fig. 5(A)–(C). Those corresponding to the bubble’s radius at each
frame are shown at the centre row, and the time series of mean
bubble radius (PFH: N = 26, PFP–PFH mixture: N = 27, PFP:
N = 59) are shown in the right row. For the PFH and PFP–PFH mix-
ture droplet, generated bubbles shrank rapidly after the vapourisa-
tion and disappeared. However, for the PFP droplet, the generated
bubble undergoes an expansion–shrinkage-expansion process
before settling to its final size after the vapourisation.3.2. Optical measurements for the four-vapourisation-pulse
transmission ultrasound sequence
Time-lapse changes of the mean vapourised area (N = 4) are
shown in Fig. 6. (A) is the result for PFH, (B) is the result for PFP–
PFH mixture and (C) is the result for PFP PCNDs. Shaded areas rep-
resent double standard deviations. The PCND-derived bubbles dis-
appeared in approximately 10 ls when the ambient temperature
(37 C) was lower than the boiling point, whereas they remained
when the ambient temperature (37 C) was higher than the boiling
point.
Fig. 7 shows the time-dependence of a mean intensity profile
(N = 4) of the video sequences; the vertical axis indicates the
ultrasound-propagation direction. The vertical white line repre-
sents the presence of bubbles. The regions of noise near 1 and
4.5 mm are the shadow of the condenser lens attached to the light
source. As shown in Fig. 7, the PFH and PFP–PFH mixture PCND-
derived bubbles disappeared after vapourisation; however, PFP
PCND-derived bubbles remained in the bubble state for relatively
long periods of time.4. Discussion
4.1. Disappearing and remaining PCND-derived bubbles
From the results of high-speed imaging and time-lapse change
of the mean vapourised area shown in Figs. 2 and 3, PCND-
derived bubbles remained in a bubble state when the boiling point
of the internal composition was lower than the ambient tempera-
ture, while they lost their optical contrast after approximately
10 ls by re-condensation or dissolution when the boiling point
Fig. 5. Time series of vapourisation process for a single droplet of (A) PFH, (B) PFP–PFH mixture and (C) PFP at 37 C in the left row, the corresponding bubble’s radius in the
middle row, and the plot of mean bubble radius. Error bars represent double standard deviations.
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ture. Dissolution rarely occurred because more than ms-order
bubble-lifetimes were obtained even for the uncoated bubble
[42]. Recondensation phenomena have been suggested by both
previous optical [30] and acoustic [34] studies. Moreover, previous
studies also supported the recondensation hypothesis, as the
micron-sized phase-change droplets still retained their coating
materials after vapourisation [32]. Therefore, we assumed that
the recondensation led to the loss of their optical contrast. Though
impossible to discern from the current experimental setup, bub-
bles in close proximity are likely to fuse [30,43] and resulting in
a gradual change in mean droplet size. Moreover, the encapsulat-
ing shell might become sparse by ultrasound pulses after vapouri-
sation [32,44,45] and number of agents might decrease with
repetitive pulsing.
Fig. 3 shows that there was a dip after the first expansion of the
long-bubble-lifetime group. This dip was also observed in the
results of bubble radius measurements shown in Fig. 5(C) as an e
xpansion–shrinkage-expansion process after vapourisation. A
radial expansion of approximately 5 (calculated from ideal gas
law) might occur upon vapourisation of a PFP droplet. Therefore,
radius of 1 lm size bubbles are expected to be obtained from the
radius of 200 nm PFP droplet. However, the mean radius of the
final bubbles that originated from PFP droplets was 3.7 ± 1.4 lm
which is more than 18 times the original diameter. This such a
big difference in the expected bubble size and the observed bubble
size might be because generated bubbles were originated from thelarger droplets in the sample, some of the droplets aggregated in
the sample and fused after vapourisation, or non-condensable
gas flowed into the bubbles while volume expansion–shrinkage
process [46].
Fig. 6 implicates that droplets have the potential to re-vapourise
after recondensation. However, it is uncertain whether the
vapourisations confirmed by the second pulse originated from
the same droplets vapourised by the first pulse. We need to further
investigate whether recondensed droplets possess the potential to
re-vapourise under exposure to an additional vapourisation pulse.
As shown in Fig. 4, while there were variances among the types
of PCNDs, the vapourisation threshold (which was a function of the
negative pressure) decreased as the ambient temperature
increased, which led to an increase in the maximum vapourisation
area. This might have been because an increase in ambient temper-
ature resulted in an increase in the vapour pressure of the PFC [47]
and a decrease in the peak-negative pressure required for vapouri-
sation. Similar findings were reported by Reznik et al. [17], Zhang
and Porter [20] and Fabiilli et al. [48].
For application as an ultrasound contrast agent, the recondensa-
tion case is most desirable. PCNDs as ultrasound contrast agents
are intended to be used for identifying tumour regions by EPR
effects. A general way to identify the tumour region or the amount
of accumulation of PCNDs by ultrasound is to vapourise the PCNDs.
When considering the case in which the vapourised PCNDs remain
in the bubble state for a long period of time, intravascular
PCNDs could not reach the extravascular region once vapourised.
Fig. 6. Time-lapse change of mean vapourised area (N = 4) exposed to 4 subsequent
vapourisation pulses at 37 C.(A) is the result for PFH, (B) is the result for PFP–PFH
mixture and (C) is the result for PFP PCNDs. Shaded areas represent double standard
deviations.
Fig. 7. Time-dependences of the mean intensity profiles (N = 4) of the video
sequences. Four-shot-ultrasound vapourisation pulses were exposed to three
different types of PCNDs; (A) PFH, (B) PFP–PFH mixture and (C) PFP. The vertical
white line represents the presence of a bubble.
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(PCND) significantly after finishing the imaging process. For appli-
cation as a HIFU-sensitiser, the remaining and coalescence cases
are desirable because it is desirable to maintain a HIFU-
sensitising effect for a long period of time during HIFU-ablation
therapy.
In the following paragraph, the advantages of bubble-lifetime
controlling methods by change of the ambient temperature condi-
tion are discussed. Two methodologies for controlling the bubble-
lifetime have been proposed in this study: changing the internal
composition of the PCNDs and changing the ambient temperature
conditions. However, the internal composition change of the
PCNDs might induce a change of the accumulation efficiency
because of the size differences, or a change in the stability of a dro-
plet state during intravascular circulation. Therefore, it is very
advantageous to control the bubble-lifetime by changing the ambi-
ent temperature condition rather than using multiple internalcompositions. Future work will include investigating the precise
transition temperature point that determines the lifetime of the
generated bubble.
Several methods have previously been developed to control the
ambient temperature condition in vivo. Focused ultrasound is one
of the potential candidates for our approach to realizing non-
invasive heating within a single modality and has been proposed
for hyperthermia treatment of tumour tissue [49].
4.2. Shielding effects of PCND-derived bubbles
As shown in Figs. 6 and 7, vapourised area-expansion phenom-
ena were confirmed at the second shot. In addition, there was no
significant increase in newly generated bubbles at the focus of
the ultrasound for the long-lifetime group, while the increase of
the vapourised area was caused by the pre-focal area. This phe-
nomenon occurred due to the ultrasound-propagation shielding
effect of the PCND-derived bubbles.
The processes of reflection of ultrasound by the bubbles and
generation of the bubbles themselves are described in the litera-
ture [2]. The shielding effect for phase-change droplets has also
been reported by several other groups [22,50,51] and was inti-
mated by studies on the use of PCNDs as HIFU-sensitisers [20].
Thus, when using PFP PCND-derived bubbles as ultrasound con-
trast agents, poor vapourisation control, such as vapourising
PCNDs at high concentration, might not lead to the imaging of all
generated bubbles, but only of the bubbles generated near the
transducer.
5. Conclusions
In this study, we used an optical measurement system to mea-
sure the vapourisation of the PCNDs and the stability (bubble-
lifetime) of the resulting bubbles and to investigate the stability-
controlling mechanism of nucleated bubbles at ls-order while
changing the internal composition of PCNDs and the ambient tem-
perature. PCND-derived bubbles remained in a bubble state when
the boiling point of the internal composition was lower than the
ambient temperature, whereas they lost their optical-contrast in
104 A. Ishijima et al. / Ultrasonics 69 (2016) 97–105approximately 10 ls by re-condensation or dissolution when the
boiling point of the internal composition was higher than the
ambient temperature. We revealed that the superheating condition
significantly affects the fate of vapourised PCNDs and that the
bubble-lifetime can be controlled by changing the ambient
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